Heather Hobbs NEWS&VIEWS Bringing you the latest Business News and updates from the Science Industry Neurosurgery Device Gaining Recognition
Vycor Medical, Inc, a medical device company that designs, develops and markets next generation neurosurgery devices is confident that its ViewSite Brain Access System (VBAS) medical retraction instrument is advancing its market share, describing the retractor as a "BioTech Breakthrough" with the potential to impact several hundreds of thousands of patients and throngs of surgeons and medical facilities worldwide.
"Most are shocked to learn that neurosurgical retraction technology has not significantly changed in nearly a century," said Heather N.
Vinas, president of Vycor Medical, Inc. “Where other forms of diagnostic and operative procedures have evolved by leaps and bounds, this crucial area of surgery has remained virtually unchanged to the detriment of patients, physicians and surgical facilities, alike. Vycor has single-handedly changed all that with a neurotech advancement that's also fiscally sound."
VBAS is said to offer a less invasive way to access surgical locations and perform critical procedures with minimal damage to surrounding brain tissue, thus minimising collateral trauma and accelerating post-operative recovery. Given the estimated
600,000 brain surgeries conducted annually around the globe, this is a very significant and sizeable problem that ViewSite is directly - and aggressively – addressing, the company claimed.
Michael W. Weaver, MD Assistant Professor of Neurosurgery a Temple University noted: "The ViewSite Brain Access System provides a minimally traumatic surgical corridor to deep seated brain tumours, resulting in effective and efficient tumor removal with minimal morbidity. I have been extremely pleased with the results of the surgeries I have performed with the ViewSite.”
TO FIND OUT MORE CIRCLE NO.
Analytik Jena Development Head Receives Award for Outstanding Service
Dr Gerhard Schlemmer, head of the Research and Development division at Analytik Jena AG, has been presented with the Ioannes Marcus Marci Medal for outstanding developments in the field of atomic spectroscopy. The prestigious prize is awarded every two years by the Czech- Slovak Spectroscopic Society, which met from May 31 to June 3 in Litomysl, Czech Republic.
"Naturally, Analytik Jena pays special recognition to the services of Dr Schlemmer with pride and pleasure. For many years, Dr. Schlemmer has performed exceptional work in the research and development of analytical instrumentation technology at Analytik Jena.
He has made a crucial contribution to ensuring that in the contrAA®
technology, the company
offers a product with the utmost innovation in the field of atomic absorption spectrometry. This remains an important selling proposition and a significant guarantee of sales for the company in a fiercely competitive global market", commented Klaus Berka, CEO of Analytik Jena AG
Schlemmer, 58, has been an analytical chemist and spectroscopist for 30 years. He has been responsible for research and development at Analytik Jena since summer 2004, having joined the company in 2002.
WITec Strengthen Industrial Market
WITec GmbH has acquired a majority holding of optical measurement solution provider omt optische messtechnik gmbh, which will enhance WITec’s’ market position in the field of measurement technology for industrial applications. Omt is regarded as having strong capability in measurement of parameters such as film thickness, colour, sheet resistance, moisture and chemical composition through provision of
in-line and laboratory devices leveraging techniques such as reflectometry, spectral ellipsometry, video microscopy and spectroscopy, which will complement the structural, optical and chemical imaging instrumentation WITec already supply, a spokesman said. omt will continue to operate as an independent company in the future. “Our goal is the extension of our market-leading position in the field of 3D surface
analysis. With the acquisition of a majority holding in omt we will be active in additional but distinct and vital sectors which will lead to further growth potential,” said WITec MD Dr Joachim Koenen. “WITec is the partner of choice for omt, enabling us to secure our future growth and to approach new markets and technological segments,” added omt Managing Director Dr Matthias Eberhardt
TO FIND OUT MORE CIRCLE NO. 52 Victoria Brooks and Michael Sauer
Two recent additions to the marketing department at Peter Huber Kältemaschinenbau GmbH are Victoria Brooks and Michael Sauer. Michael, who joined in July, was leader of marketing communications for a German temperature control equipment manufacturer, which provided him with a good knowledge of the industry. He joins Victoria, who has been with Huber since the beginning of the year and previously worked for a laboratory equipment dealer and supplier of the Huber range in the UK. Both of them will take over wide ranging responsibilities in both national and international marketing. Managing Director Daniel Huber is pleased about the new additions. “The native English speaker Victoria, is marketing specialist for the English speaking customers and together with Michael Sauer, an experienced colleague, they are valuable members of the marketing team. After rapid expansion in the previous years, the strengthening comes at just the right time, and offers us new possibilities to further expand our marketing position.” Michael Sauer added “the innovative strength of the Huber Company has always impressed me, and I am happy with the new duties and responsibilities as part of this young international team.”
TO FIND OUT MORE CIRCLE NO. 53 49
PuriCore Appoints Executive Chairman
Puricore, the water-based clean technology company has announced the appointment of Chris Wightman as Executive Chairman. Non-Executive Chairman since 2002, Wightman, based in the UK, will assume responsibility for the Company’s long-term strategy and investor relations. This appointment will enable Greg Bosch, CEO, based in the US, to focus more time on the operational delivery of the Company’s business plans.
“Given the increasing challenges of managing the UK listing from the US as our two core businesses continue to expand, this change will enable the Company to capitalise on the Executives’ complementary strengths and geographic locations. As a result, PuriCore will increase focus on the tasks of driving profit and margin in the Company’s operating businesses and improving the visibility of the Company’s technology and potential amongst existing and future shareholders,” Mr Wightman said
TO FIND OUT MORE CIRCLE NO. 50 Dr Gerhard Schlemmer TO FIND OUT MORE CIRCLE NO. 51
Diagnostics Marketing Manager Joins BBI
Dr Nanette Bartram has joined the BBI Diagnostics division and brings a wealth of experience of working in both diagnostic and life science companies such as Invitrogen, Dynal Biotech, and Bio-Rad Laboratories in a number of roles including marketing, field sales, business development and product management.
Nanette’s role will be to ensure continued commercial success and to further enhance BBI’s reputation in the lateral flow test market, while expanding the portfolio of reagents and services offered by the company. “I am delighted to be part of such a successful and dynamic company which is ideally positioned to exploit the rapidly expanding global diagnostics markets,” Nanette said.
Penny McCormick Head of Marketing stated “We are delighted with the addition Nanette to the team. The experience she brings will be a great compliment as we look to strengthen our position in the marketplace. This is just one example of how BBI continue to invest in the business, and we look forward to this continued success.”
TO FIND OUT MORE CIRCLE NO. 54
TO BE INCLUDED IN OUR NEXT ISSUE, SEND ALL YOUR BUSINESS AND FINANCIAL NEWS STORIES TO
HEATHER@INTLABMATE.COM
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
